Financing, Equity Capital Markets
TapImmune, Inc. nka Marker Therapeutics
10/18
|
$70.0 Million
做厙勛圖 served as sole agent for TapImmune, Inc. on a PIPE offering
Sub-Type
PIPE
Sector
Sub-Sector
Biopharma